Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
The approval of BRACAnalysis for women with ovarian cancer in Japan
June 19, 2019 Off

The approval of BRACAnalysis for women with ovarian cancer in Japan

By Dino Mustafić

Japanese Ministry of Health, Labour, and Welfare has granted a second manufacturing and marketing approval for Myriad Genetics’ subsidiary, Myriad Genetic Laboratories, for BRACAnalysis Diagnostic System as a companion diagnostic with the PARP inhibitor, Lynparza, marketed by AstraZeneca and Merck.

June 19, 2019 Off

Resolution Advancing Development of Cell-Free DNA Companion Diagnostic for Prostate Cancer through Collaboration with Janssen

By BusinessWire

Liquid biopsy assay with recent Breakthrough Device Designation from FDA is being used to screen patients with prostate cancer for…

June 19, 2019 Off

Specialized Life Sciences Job Board Now Available in Quebec Thanks to BioTalent Canada and BIOQuébec

By BusinessWire

MONTREAL–(BUSINESS WIRE)–#HR–BIOQuébec and BioTalent Canada have announced a collaboration agreement to facilitate access to human resources services specific to life…

June 19, 2019 Off

Cortexyme Expands Clinical Advisory Board With Key Clinical and Regulatory Experts

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to…

Uterine Fibroids Market Spotlight, 2026 – Repros Therapeutics has the Highest Number of Completed Clinical Trials
June 19, 2019 Off

Uterine Fibroids Market Spotlight, 2026 – Repros Therapeutics has the Highest Number of Completed Clinical Trials

By BusinessWire

It is estimated that there were approximately 92.2
million prevalent cases of uterine fibroids worldwide in females aged
15 years and over, and forecasts that number to increase to 102.7
million prevalent cases by 2026.

June 19, 2019 Off

Global Anti-tuberculosis Therapeutics Market Growth, Trends and Forecasts Through 2019-2024 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Anti-tuberculosis Therapeutics Market Growth, Trends and Forecasts Through 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The…

June 19, 2019 Off

Global Irritable Bowel Syndrome (IBS) Market Spotlight 2017-2026 – Allergan Leads Industry Sponsors with the Highest Number of Clinical Trials, Followed by GSK and Novartis – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Irritable Bowel Syndrome (IBS)” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers…

June 19, 2019 Off

Global Duchenne Muscular Dystrophy (DMD) Market Spotlight 2017-2018 & 2019-2026 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Duchenne Muscular Dystrophy (DMD)” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers…

June 19, 2019 Off

Global Thyroid Cancer Market Spotlight 2017-2018 & 2019-2026 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Thyroid Cancer” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the thyroid…

June 19, 2019 Off

Global Polycystic Kidney Disease Drugs Market 2019-2023 | 6% CAGR Projection over the Next Five Years | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–#Biotechnology–The global polycystic kidney disease drugs market is expected to post a CAGR of more than 6% during the…

Posts pagination

Previous 1 … 3,064 3,065 3,066 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine